Literature DB >> 26622877

Radiological and clinical results following high-dose intensity-modulated radiotherapy in recurrent craniopharyngioma: A case report.

Antonio Pierro1, Savino Cilla2, Vincenzo Picardi3, Marica Ferro3, Gabriella Macchia3, Francesco Deodato3, Milly Buwenge3, Giuseppina Sallustio1, Alessio G Morganti4.   

Abstract

Craniopharyngiomas (CPs) are rare benign suprasellar tumors. The standard treatment for CP is complete surgical resection or partial resection followed by adjuvant radiotherapy (RT). Adjuvant RT is typically administered at a total dose of 54 Gy with 1.8 Gy/fraction. The current study reported the case of a young patient affected by recurrent craniopharyngioma, who was treated with irradiation subsequent to several surgical resections. Image fusion and intensity-modulated radiation therapy techniques were employed to deliver a high total dose (63 Gy with 2.1 Gy/fraction) with no severe acute toxicities recorded. At the 6-year follow-up, no radiological or clinical signs of disease progression or late sequelae were observed.

Entities:  

Keywords:  case report; craniopharyngioma; intensity-modulated radiation therapy; pediatric

Year:  2015        PMID: 26622877      PMCID: PMC4580017          DOI: 10.3892/ol.2015.3514

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  12 in total

Review 1.  Imaging of craniopharyngioma.

Authors:  John G Curran; Erin O'Connor
Journal:  Childs Nerv Syst       Date:  2005-08-03       Impact factor: 1.475

2.  CT and MR imaging of craniopharyngioma.

Authors:  M Tsuda; S Takahashi; S Higano; N Kurihara; H Ikeda; K Sakamoto
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

3.  On the benefits and risks of proton therapy in pediatric craniopharyngioma.

Authors:  Chris Beltran; Monica Roca; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-11       Impact factor: 7.038

4.  Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation.

Authors:  Tejpal Gupta; Tabassum Wadasadawala; Zubin Master; Reena Phurailatpam; Rajershi Pai-Shetty; Rakesh Jalali
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-23       Impact factor: 7.038

5.  Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.

Authors:  W J Hader; P Steinbok; J Hukin; C Fryer
Journal:  Pediatr Neurosurg       Date:  2000-10       Impact factor: 1.162

Review 6.  Radiation therapy in the management of pediatric craniopharyngiomas--a review.

Authors:  John A Kalapurakal
Journal:  Childs Nerv Syst       Date:  2005-06-17       Impact factor: 1.475

Review 7.  Craniopharyngiomas.

Authors:  Niki Karavitaki; Simon Cudlip; Christopher B T Adams; John A H Wass
Journal:  Endocr Rev       Date:  2006-03-16       Impact factor: 19.871

8.  Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.

Authors:  S H Choi; B J Kwon; D G Na; J-H Kim; M H Han; K-H Chang
Journal:  Clin Radiol       Date:  2007-02-26       Impact factor: 2.350

9.  Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible?

Authors:  Francesco Deodato; Savino Cilla; Mariangela Massaccesi; Gabriella Macchia; Edy Ippolito; Luciana Caravatta; Vincenzo Picardi; Michele Romanella; Carlo Di Falco; Alessandra Bartollino; Vincenzo Valentini; Numa Cellini; Marco De Spirito; Angelo Piermattei; Alessio G Morganti
Journal:  Tumori       Date:  2012 Jul-Aug

10.  Minimally invasive management of adult craniopharyngiomas: An analysis of our series and review of literature.

Authors:  Gazanfar Rahmathulla; Gene H Barnett
Journal:  Surg Neurol Int       Date:  2013-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.